FDA recall D-0939-2023

Glenmark Therapeutics, Inc. · Class II · drug

Product

Famotidine Tablets, USP, 20mg, 200-count bottle within a carton, Distributed by: Glenmark Therapeutics Inc., USA, Mahwah, NJ 07430, Made in India, NDC 72657-113-20.

Reason for recall

Labeling: Label Error on Declared Strength: some cartons labeled and containing 20 mg may have an external label placed on the side of the carton indicating strength as 10 mg.

Distribution

Nationwide in the USA

Key facts

Status
Terminated
Initiation date
2023-05-01
Report date
2023-07-26
Termination date
2024-09-17
Voluntary/Mandated
Voluntary: Firm initiated
Location
Mahwah, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0939-2023